TUMI, a leading international travel brand, is wrapping up its 50th anniversary year by celebrating its heritage. The brand’s striking colorway of black and TUMITUMI, a leading international travel brand, is wrapping up its 50th anniversary year by celebrating its heritage. The brand’s striking colorway of black and TUMI

Tumi goes black and red to mark 50th year

TUMI, a leading international travel brand, is wrapping up its 50<sup>th</sup> anniversary year by celebrating its heritage.

The brand’s striking colorway of black and TUMI Red — its signature Pantone — is featured in select pieces from the Alpha, Alpha Bravo, Voyageur, and 19 Degree Aluminum collections, including backpacks, totes, and small travel accessories, just in time for the holiday season.

“These colors celebrate TUMI’s heritage while signaling its continued evolution: bold, resilient, and built for the journey ahead,” the brand said in a statement.

The red and black colorway can be found in the Celina Backpack, Dey Trunk Crossbody, Just In Case Tote, and Double Expansion Backpack.

TUMI also offers a premium gifting range with the 19 Degree Aluminum collection that combines timeless design and durability. Standout pieces include the International Carry-On, Cigar Case, Sunglass Case, and Compact Mirror.

There is also a 19 Degree Aluminum Bar Set which extends TUMI’s 19 Degree design code for the home. The set includes everything needed to make a perfect cocktail, including custom recipe cards.

“The most meaningful gifts are the ones that become part of everyday life,” said Victor Sanz, TUMI’s creative director, in a statement.

“The best gifts fit seamlessly into everyday life — accompanying you from work to travel to home — and are as meaningful to give as they are to use long after the season ends.”

GIFT IDEAS
For men, TUMI highlights backpacks from the Arrivé and Harrison collections, along with leather accessories such as a reversible belt — practical options suited for work, travel and daily use.

In particular, the Barker and Larson backpacks offer aerodynamic silhouettes with automotive-inspired touches.

For women, TUMI’s gift picks include structured bags from the Olas and Agent collections, designed to move easily from office to evening.

The Belden line includes jewelry cases, passport cases, and wallet-on-chain styles in seasonal hues for the holiday season.

For TUMI, personalization remains part of the holiday assortment, with monogramming available on select items.

The anniversary and holiday pieces are available at TUMI stores and TUMI.com.

Market Opportunity
BLACKHOLE Logo
BLACKHOLE Price(BLACK)
$0.03556
$0.03556$0.03556
-3.42%
USD
BLACKHOLE (BLACK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26